STAT Plus: Pharmalittle: WHO seeking wide access to remdesivir; Gavi proposes incentives for a Covid-19 vaccine

The WHO plans to speak with the U.S. government and Gilead Sciences about how the experimental remdesivir drug could be made more widely available to treat Covid-19.

Click to view original post